Micro cap Rigel Pharmaceuticals (RIGL +4%) has perked up over the past month as long investors take positions ahead of the company's release of data this month from two identical Phase 3 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback